Cargando…

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection

ccJE+Advax is an inactivated cell culture Japanese encephalitis (JE) vaccine formulated with Advax, a novel polysaccharide adjuvant based on delta inulin. This vaccine has previously shown promise in murine and equine studies and the current study sought to better understand its mechanism of action...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komiya, Tomoyoshi, Honda-Okubo, Yoshikazu, Baldwin, Jeremy, Petrovsky, Nikolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618450/ https://www.ncbi.nlm.nih.gov/pubmed/34835166 http://dx.doi.org/10.3390/vaccines9111235

Ejemplares similares

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2021)

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
por: Lobigs, Mario, et al.
Publicado: (2010)

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
por: Gordon, David L., et al.
Publicado: (2016)

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
por: Li, Lei, et al.
Publicado: (2022)

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
por: Wanandy, Troy, et al.
Publicado: (2019)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
por: Petrovsky, Nikolai, et al.
Publicado: (2015)

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2023)

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
por: Li, Lei, et al.
Publicado: (2021)

Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin
por: Petroski, N.
Publicado: (2017)

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
por: Bielefeldt-Ohmann, Helle, et al.
Publicado: (2014)

Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine
por: Li, Lei, et al.
Publicado: (2015)

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)

Alzheimer’s disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
por: Davtyan, Hayk, et al.
Publicado: (2016)

Pathogenesis of flavivirus encephalitis
por: Chambers, Thomas J, et al.
Publicado: (2003)

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective
por: Baldwin, Jeremy, et al.
Publicado: (2021)

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2023)

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations
por: Tabarsi, Payam, et al.
Publicado: (2022)

Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
por: Tomar, Jasmine, et al.
Publicado: (2018)

Antiviral macrophage responses in flavivirus encephalitis
por: Ashhurst, Thomas Myles, et al.
Publicado: (2013)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
por: Kaushik, Deepender, et al.
Publicado: (2020)

Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses
por: Oliveira, Renato AS, et al.
Publicado: (2019)

Label-Free Electrochemical Biosensors for the Determination of Flaviviruses: Dengue, Zika, and Japanese Encephalitis
por: Khristunova, Ekaterina, et al.
Publicado: (2020)

Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice
por: Alzua, Garazi Pena, et al.
Publicado: (2023)

Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus
por: Higuchi, Akira, et al.
Publicado: (2016)

Age Affects Quantity but Not Quality of Antibody Responses after Vaccination with an Inactivated Flavivirus Vaccine against Tick-Borne Encephalitis
por: Stiasny, Karin, et al.
Publicado: (2012)

Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase
por: Brecher, Matthew, et al.
Publicado: (2015)

Broad Host Tropism of Flaviviruses during the Entry Stage
por: Zhang, Yanan, et al.
Publicado: (2023)

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
por: McAuley, Alexander J., et al.
Publicado: (2017)

Epidemiological study on Japanese encephalitis virus distribution in Ishikawa prefecture, Japan, by serological investigation using wild boar sera
por: KOMIYA, Tomoyoshi, et al.
Publicado: (2019)

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
por: Petrovsky, Nikolai
Publicado: (2015)

Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine
por: Li, Yifan, et al.
Publicado: (2023)

Emergence of Usutu virus, an African Mosquito-Borne Flavivirus of the Japanese Encephalitis Virus Group, Central Europe
por: Weissenböck, Herbert, et al.
Publicado: (2002)

Novel synthetic nucleotides of notifiable dengue (1–4), Japanese encephalitis, yellow fever and Zika flaviviruses
por: Camer, Gerry Amor, et al.
Publicado: (2018)

Selective Reactivity of Anti-Japanese Encephalitis Virus NS4B Antibody Towards Different Flaviviruses
por: Kaufusi, Pakieli H., et al.
Publicado: (2020)

Immunoglobulin M seroneutralization for improved confirmation of Japanese encephalitis virus infection in a flavivirus-endemic area
por: Bharucha, Tehmina, et al.
Publicado: (2022)

Immunization with Heterologous Flaviviruses Protective Against Fatal West Nile Encephalitis
por: Tesh, Robert B., et al.
Publicado: (2002)

To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1
por: Griffith, Sarah A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_od2u9vganmrgv4knt3lk4ai231